What will I pay for the visit—and after it?

A visit price may leave medicine out.

Use the questions below for the care you are considering. The price examples are for services and medicines used for weight loss or diabetes.

As of September 2026, some online services for weight loss charge a membership fee for ongoing care and charge separately for medicine.

Ask for today’s full price, the charges that recur, and the prices that apply once the offer has finished.

What belongs in the price breakdown?

Keep the answers together so each offer can be compared on the same terms.

Medicine can be a separate monthly cost.

As of September 2026, drug makers’ prices paid without insurance for several weight-loss and diabetes medicines mostly range from about $149 to $499 a month.

Some offers cost more if you order the next supply after the offer’s refill deadline.

A “month” may mean a set number of days, a box, or a bottle, depending on the product.

These figures describe medicine alone, before separate care or test fees.

Ask for the price of your own medicine, how much that price includes, and the last date you can reorder at that price.

How can one medicine come with several prices?

As of September 2026, list prices, cash offers, insurance offers, and government programmes use different prices for the same drug.

List price means the maker’s published price.

A self-pay price means paying for the medicine outside insurance.

An offer’s price may depend on the exact product, how much medicine it contains, and when you order the next supply.

A low starting price may end after the first few orders.

Ask your health insurance plan about the exact medicine and the reason for treatment. If it needs prior authorization, that means a review before the plan agrees to pay.

Ask what you pay if that review is declined. For a starting offer, ask how many orders get that price, when the offer ends, and what each order costs afterwards.

Ask about the temporary medicine programme.

Hunger and blood sugar involve a body signal called GLP-1; some medicines act by copying it.

As of September 2026, people who qualify for Medicare’s temporary GLP-1 Bridge programme can get certain weight-loss medicines for a monthly copay of $50.

A copay is the share the patient pays.

Part D is Medicare’s usual insurance for medicines that need a prescription, an order from a health professional.

The programme runs from July 2026 through December 2027 and pays for medicine separately from your usual Part D insurance.

You must be at least 18 and satisfy the programme’s rules for weight, other health problems, and your Medicare drug-plan type.

You also need a prescription—an order for the medicine—and approval before the programme pays.

If your GLP-1 medicine was covered by Part D in 2026, the Bridge programme is unavailable to you in 2026.

Ask the doctor who would order the medicine to check these rules for you.

People with type 2 diabetes, which affects blood sugar, cannot use the Bridge programme; their medicine is considered for usual Part D cover instead.

Your $50 Bridge payment does not count toward the annual limit your Part D plan sets for your own medicine spending.

You still owe the Bridge payment even after reaching that limit.

This payment stays $50 even if you get Medicare’s help with prescription costs because your income is low.

Coupons cannot be added to that copay.

Ask the doctor and your Medicare drug plan whether the Bridge programme or your usual Part D cover applies to your care. Ask for your own cost under that option, and ask about visit fees separately.